July 1st 2025
How clinical operations teams can close the gap between controlled trial results and real-world adoption by generating evidence in broader, more representative patient populations.
September 10th 2024
The OSCAR Study: Unlocking the Power of Real-World Evidence in Cancer-Associated Thrombosis
February 3rd 2023Craig Coleman, PharmD, Professor at the University of Connecticut, and the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban (OSCAR) study's principal investigator discusses the ins and outs of the study.
Cardiovascular and Metabolic Studies Emphasize Innovative Advancements, Patient Centricity, and RWE
March 26th 2019Karen Hill and Heather Fitzpatrick Medlin discuss the recent advancements and challenges in cardiovascular and metabolic studies, as well as strategies to address current obstacles and advance the industry further.